tiprankstipranks
Trending News
More News >
Sugi Holdings Co (JP:7649)
:7649

Sugi Holdings Co (7649) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Sugi Holdings Co

(OTC:7649)

Rating:74Outperform
Price Target:
Sugi Holdings Co demonstrates strong financial performance with solid growth and stability across income, balance sheet, and cash flow metrics. The technical analysis supports a positive market sentiment, though the valuation is moderate, reflecting a balanced investment opportunity. The overall score is driven primarily by the company's robust financial foundation and positive technical indicators.

Sugi Holdings Co (7649) vs. iShares MSCI Japan ETF (EWJ)

Sugi Holdings Co Business Overview & Revenue Model

Company DescriptionSugi Holdings Co.,Ltd. operates drugstores in Japan. It also provides visiting nursing services and home care support services. As of June 1, 2019, the company operated 1,190 stores. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
How the Company Makes MoneySugi Holdings Co., Ltd. generates revenue primarily through the sale of pharmaceutical products, over-the-counter drugs, and a diverse range of health and beauty items. The company's pharmacies are strategically located to serve a broad customer base, providing both prescription fulfillment services and retail sales. Revenue streams are bolstered by its ability to attract repeat customers through loyalty programs and personalized healthcare services. Additionally, Sugi Holdings benefits from economies of scale and strong supplier relationships, which contribute to its profitability. The company also explores opportunities for expansion and diversification to drive growth, including partnerships with healthcare providers and leveraging technology to enhance customer experience.

Sugi Holdings Co Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue827.96B744.48B667.65B625.48B602.51B541.96B
Gross Profit257.54B228.84B202.52B191.49B181.29B162.18B
EBITDA42.38B46.24B44.02B43.41B43.64B38.17B
Net Income24.79B21.98B19.01B19.39B21.12B20.78B
Balance Sheet
Total Assets535.91B390.56B351.89B334.76B345.93B313.76B
Cash, Cash Equivalents and Short-Term Investments73.98B47.43B70.64B71.83B95.84B91.35B
Total Debt47.19B837.00M1.95B2.31B2.33B1.61B
Total Liabilities291.48B157.20B135.36B120.87B145.30B131.01B
Stockholders Equity244.43B233.36B216.54B213.89B200.63B182.75B
Cash Flow
Free Cash Flow0.006.34B16.77B-16.20B12.46B24.97B
Operating Cash Flow0.0039.04B38.28B7.17B34.03B45.35B
Investing Cash Flow0.00-30.98B-23.26B-23.89B-29.25B-18.42B
Financing Cash Flow0.00-5.28B-14.21B-5.29B-5.27B-4.89B

Sugi Holdings Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3279.00
Price Trends
50DMA
3128.08
Positive
100DMA
2961.78
Positive
200DMA
2757.84
Positive
Market Momentum
MACD
47.43
Negative
RSI
62.14
Neutral
STOCH
76.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7649, the sentiment is Positive. The current price of 3279 is above the 20-day moving average (MA) of 3203.05, above the 50-day MA of 3128.08, and above the 200-day MA of 2757.84, indicating a bullish trend. The MACD of 47.43 indicates Negative momentum. The RSI at 62.14 is Neutral, neither overbought nor oversold. The STOCH value of 76.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7649.

Sugi Holdings Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥620.46B23.1910.45%1.22%17.94%18.31%
51
Neutral
$7.50B0.32-61.87%2.27%17.10%1.59%
$3.66B18.1311.61%0.02%
$3.80B18.714.93%0.04%
78
Outperform
¥384.86B20.16
0.38%14.79%35.84%
74
Outperform
¥524.15B34.80
1.43%5.56%-43.50%
70
Neutral
¥729.53B24.67
102.62%6.96%18.31%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7649
Sugi Holdings Co
3,279.00
1,075.05
48.78%
SDGCF
Sundrug Co
31.20
7.47
31.48%
TSUSF
TSURUHA Holdings
55.00
0.31
0.57%
JP:3141
Welcia Holdings Co., Ltd.
2,514.00
573.14
29.53%
JP:3349
COSMOS Pharmaceutical Corporation
9,090.00
2,607.85
40.23%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,664.00
770.47
26.63%

Sugi Holdings Co Corporate Events

SUGI Holdings Completes Treasury Stock Disposition
Jun 13, 2025

SUGI Holdings Co., Ltd. has completed the payment procedures for the disposition of treasury stock as restricted stock remuneration, a decision made by its Board of Directors on May 27, 2025. This move involves the distribution of 7,044 shares of common stock to various directors and executive officers, amounting to a total disposition value of 22,195,644 yen, potentially impacting the company’s financial strategy and stakeholder interests.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Maintains Independence Amid Significant Shareholder Ownership
May 30, 2025

SUGI Holdings Co., Ltd. has disclosed information regarding Sugi Shoji Co., Ltd., which holds 37.43% of its voting rights. Despite this significant ownership, Sugi Shoji does not impose any restrictions on SUGI Holdings’ business activities, and there are no plans to change this arrangement, ensuring stability in the company’s operations and management.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Announces Treasury Stock Disposition for Executive Incentives
May 27, 2025

SUGI Holdings Co., Ltd. has announced a resolution to dispose of 7,044 shares of its treasury stock as part of its restricted stock remuneration system. This initiative aims to incentivize directors and executive officers to enhance corporate value and align their interests with shareholders. The move is expected to strengthen the company’s governance and motivate key personnel by tying their compensation to the company’s stock performance.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 01, 2025